-
1
المؤلفون: Tatsuya Nitawaki, Takuro Sakagami, Naoki Shingu, Yuko Sekido, Yuko Yasuda, Aiko Nakano, Kodai Kawamura, Yoshihiko Sakata, Yoshitomo Eguchi, Jumpei Hisanaga, Kazuya Ichikado, Miwa Iio
المصدر: Thoracic Cancer, Vol 10, Iss 12, Pp 2259-2266 (2019)
Thoracic Cancerمصطلحات موضوعية: Adult, Male, non‐small cell lung cancer, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Prognostic factor, Lung Neoplasms, Immune checkpoint inhibitors, Tumor burden, Immune checkpoint inhibitor, lcsh:RC254-282, Programmed cell death ligand 1, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biomarkers, Tumor, medicine, Humans, Molecular Targeted Therapy, prognostic biomarker, Lung cancer, Aged, Neoplasm Staging, Proportional Hazards Models, Aged, 80 and over, Receiver operating characteristic, business.industry, Proportional hazards model, Original Articles, General Medicine, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Original Article, Female, Non small cell, business, tumor burden
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20055af3f9dbba302975d5fe1162123fTest
https://doi.org/10.1111/1759-7714.13214Test -
2
المؤلفون: Kai Wang, Xiangdong Zhou, Qi Wang, Xiaoxia Cui, Xiaoyu Zhang, Chunxue Bai, Li Zhang, Jian Zhang, Jianping Zhao, Peng Song, Xiaoju Zhang, Faguang Jin, Yao Yu, Li Bai, Xiaoli Zhu, Yanbin Zhou, Chengzhi Zhou
المصدر: Thoracic Cancer
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Adolescent, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Multi‐omics, B7-H1 Antigen, Young Adult, Study Protocol, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, PD‐1/PD‐L1 inhibitor, Carcinoma, Non-Small-Cell Lung, PD-L1, Internal medicine, Biomarkers, Tumor, medicine, Humans, Molecular Targeted Therapy, predictive biomarker, Lung cancer, Aged, Response rate (survey), biology, business.industry, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Clinical trial, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Immunohistochemistry, Female, Nivolumab, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb9f8018da18f4739ee639337e1c7efTest
https://doi.org/10.1111/1759-7714.13078Test -
3
المؤلفون: Lu Si, Chuanliang Cui, Xuan Wang, Lili Mao, Bixia Tang, Xinan Sheng, Bin Lian, Jun Guo, Zhihong Chi, Yan Kong, Xieqiao Yan
المصدر: Thoracic Cancer
Thoracic Cancer, Vol 10, Iss 4, Pp 950-956 (2019)مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, medicine.medical_specialty, Esophageal Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Antineoplastic Agents, lcsh:RC254-282, Adjuvant therapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Esophagus, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, melanoma of esophagus, Cancer, General Medicine, Immunotherapy, Original Articles, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Analysis, 030104 developmental biology, medicine.anatomical_structure, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Cohort, Female, Original Article, immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669bf5646d0bfabf9b0d04ce19f1388eTest
https://pubmed.ncbi.nlm.nih.gov/30864295Test